A pilot study of IL-1 inhibition by anakinra in acute gout
about
sameAs
Developments in the scientific and clinical understanding of goutInterleukin-1 in the pathogenesis and treatment of inflammatory diseasesThe inflammasome: in memory of Dr. Jurg TschoppHorror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)CanakinumabFunction of Nod-like receptors in microbial recognition and host defenseInnate immune activation through Nalp3 inflammasome sensing of asbestos and silicaNeutrophil microvesicles resolve gout by inhibiting C5a-mediated priming of the inflammasomeFlavonoids as Cytokine Modulators: A Possible Therapy for Inflammation-Related DiseasesGout: optimizing treatment to achieve a disease cureThe Use of IL-1 Receptor Antagonist (Anakinra) in Idiopathic Recurrent Pericarditis: A Narrative ReviewThe emerging role of biotechnological drugs in the treatment of goutUric acid, hyperuricemia and vascular diseasesProgress in intra-articular therapyAn Update on PYRIN Domain-Containing Pattern Recognition Receptors: From Immunity to PathologyBeyond the NLRP3 inflammasome: autoinflammatory diseases reach adolescenceMedical therapies with adult stem/progenitor cells (MSCs): a backward journey from dramatic results in vivo to the cellular and molecular explanationsRegulation of Nlrp3 inflammasome by dietary metabolitesEvasion of inflammasome activation by microbial pathogensIntracellular innate immunity in gouty arthritis: role of NALP3 inflammasomeEngagement of fatty acids with Toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritisCOPs and POPs: modulators of inflammasome activityAsbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cellsNLRP3 inflammasome activation induced by engineered nanomaterialsIL-1R signalling is critical for regulation of multi-walled carbon nanotubes-induced acute lung inflammation in C57Bl/6 miceActivation of Proinflammatory Responses in Cells of the Airway Mucosa by Particulate Matter: Oxidant- and Non-Oxidant-Mediated Triggering MechanismsTherapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injuryThe inflammasome NLRs in immunity, inflammation, and associated diseasesThe inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesisSterile inflammation: sensing and reacting to damageGout: an Asia-Pacific update.Gouty Arthritis: A Review of Acute Management and Prevention.IL-1beta processing in host defense: beyond the inflammasomes.A novel human anti-interleukin-1β neutralizing monoclonal antibody showing in vivo efficacyColchicine for the treatment of gout.Caspase 1-independent activation of interleukin-1beta in neutrophil-predominant inflammationInflammasome sensor Nlrp1b-dependent resistance to anthrax is mediated by caspase-1, IL-1 signaling and neutrophil recruitment.Monogenic IL-1 mediated autoinflammatory and immunodeficiency syndromes: finding the right balance in response to danger signalsWhy not treat human cancer with interleukin-1 blockade?Globular Adiponectin Inhibits Lipopolysaccharide-Primed Inflammasomes Activation in Macrophages via Autophagy Induction: The Critical Role of AMPK Signaling.
P2860
Q21195376-7806CC26-F155-4944-BFF1-C2772FDF2034Q24606766-81E12238-3F9B-48C8-BAE5-A69C114FA158Q24613816-F57B5E45-BE36-466B-9FE2-9618D666AA20Q24631660-35768C66-F4FA-4F19-A691-D6EF3A0ADCE5Q24642193-F2A681FF-7ED8-4378-B64E-91A59C073F38Q24647448-88494A5B-8A35-4CB1-A445-2551A47B339FQ24649598-B9791291-2BCA-4AAF-A481-34DB3CF17670Q24658508-FDCC8995-01EB-4E63-83FE-4772AFDDDBCCQ26746303-3F63B480-2F84-4E5A-8628-974D93234DB3Q26765550-26D4560A-BCE9-4220-BCB9-EBEF15837F47Q26768281-032BE047-85D5-4842-9772-C92D28585430Q26825459-B6D20078-C701-40CD-B617-D429313D2C09Q26850727-B02BBC95-521E-4A74-8543-E47948FD2E15Q26851258-259C921F-51D0-469A-BCC2-8F42E4D0663EQ27004333-570DA5DA-F33C-49E8-AB74-F2914C7CCAE6Q27011650-B4F32728-FF51-4234-BC3C-455B7748F993Q27025291-199D1799-A0D3-4BA7-8880-9CAC34AF5F5BQ28078340-DC75D755-AC12-4B8F-9F75-F4E8B680EC5AQ28082757-76A0D1DF-CB5B-4827-AFD7-9E9B0E4B3249Q28265676-58AD5E0A-36CE-41F7-95B6-F81CFAE17148Q28384291-5A114476-7B16-4729-AFA5-F40E7190C61BQ28387485-E68448A2-97BA-4C0E-B2B4-71420D4C06A6Q28387699-8FF847D0-D1B0-4BC0-8639-CEF1E026C458Q28387817-88A6538B-B1C7-4399-B2C9-E6F7D5B49564Q28389369-461101B6-B5C7-4BFE-910D-2ACB4FB4959BQ28390698-D1765E6B-168E-48BB-8B55-68F1E677E623Q28582906-50572504-C336-4419-A8A3-371D97817DC2Q29616025-97C33710-0417-4368-9ADA-57A9D1662227Q29617049-57F33725-8B3D-4C79-8C07-9FF5ADFC7B6CQ29620014-79B2F493-8180-4EFE-9024-1BC9B17EB048Q30234091-8886A480-AF64-476F-8ED1-09CF2803B5A2Q30249531-00EC419C-89AB-4571-AD28-8DD00A0055C9Q33535878-77835281-3462-4795-A515-D1B443F47D99Q33573612-3985282C-B82C-4BFB-A5CD-D1BB769482C5Q33738046-28061457-81FA-40F3-9400-17EFED20829EQ33762651-F76F39AB-3EEB-4516-887D-53A99DE052B8Q33775499-AE575B14-461A-4114-9A5D-4D495578295AQ33798590-67E31217-D2A9-4B90-B08C-8FF6E60712C6Q33833871-76F0FDE5-6B08-4CE3-8F33-4592C25CB166Q33838982-723AD617-899E-4A23-8C2D-9152B920C279
P2860
A pilot study of IL-1 inhibition by anakinra in acute gout
description
2007 nî lūn-bûn
@nan
2007 թուականին հրատարակուած գիտական յօդուած
@hyw
2007 թվականին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
A pilot study of IL-1 inhibition by anakinra in acute gout
@ast
A pilot study of IL-1 inhibition by anakinra in acute gout
@en
A pilot study of IL-1 inhibition by anakinra in acute gout
@en-gb
A pilot study of IL-1 inhibition by anakinra in acute gout
@nl
type
label
A pilot study of IL-1 inhibition by anakinra in acute gout
@ast
A pilot study of IL-1 inhibition by anakinra in acute gout
@en
A pilot study of IL-1 inhibition by anakinra in acute gout
@en-gb
A pilot study of IL-1 inhibition by anakinra in acute gout
@nl
prefLabel
A pilot study of IL-1 inhibition by anakinra in acute gout
@ast
A pilot study of IL-1 inhibition by anakinra in acute gout
@en
A pilot study of IL-1 inhibition by anakinra in acute gout
@en-gb
A pilot study of IL-1 inhibition by anakinra in acute gout
@nl
P2093
P2860
P3181
P356
P1476
A pilot study of IL-1 inhibition by anakinra in acute gout
@en
P2093
Alexander So
Sylvie Revaz
Thibaut De Smedt
P2860
P2888
P3181
P356
10.1186/AR2143
P407
P50
P577
2007-01-01T00:00:00Z
P5875
P6179
1043880305